CSII
CSII is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes
Effects of Different Early Intensive Therapies on Long-term β-cell Function
Continuous Subcutaneous Insulin Infusion Versus Multiple Dose Insulin Injections in Routine Clinical Practice
Insulin Pump vs Multiple Daily Injection on Cardiovascular Outcomes (ITALICO)
Education Effectiveness for Type 1 Diabetes Mellitus on Insulin Pump Therapy
Clinical Trials (6)
Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes
Effects of Different Early Intensive Therapies on Long-term β-cell Function
Continuous Subcutaneous Insulin Infusion Versus Multiple Dose Insulin Injections in Routine Clinical Practice
Insulin Pump vs Multiple Daily Injection on Cardiovascular Outcomes (ITALICO)
Education Effectiveness for Type 1 Diabetes Mellitus on Insulin Pump Therapy
Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6